{
  "profile_url": "https://www.moffitt.org/research-science/researchers/robert-wenham/",
  "last_updated": "2025-11-21T22:50:26.670272",
  "researcher_id": "3149",
  "degrees": [
    "MD"
  ],
  "title": "",
  "primary_program": "gynecologic oncology",
  "research_program": "molecular medicine",
  "overview": "Dr. Wenham has a strong interest in research and is a principal investigator for numerous clinical trials to improve cancer care for women.",
  "research_interests": [
    "Dr. Wenham's research involves identifying and testing novel biological agents and chemotherapeutics for gynecologic cancers. The future of gynecologic oncology is exciting as the rapid pace of translational research is changing the outcome and quality of life for patients.\n  *"
  ],
  "associations": [
    "Gynecologic Oncology",
    "Molecular Medicine Program",
    "Center of Excellence for Evolutionary Therapy",
    "Experimental Therapeutics Program"
  ],
  "education": [
    {
      "type": "Graduate",
      "institution": "University of North Texas Health Science Center, Fort Worth, TX, MSc"
    },
    {
      "type": "Medical School",
      "institution": "University of Texas Southwestern Medical School",
      "degree": "MD"
    },
    {
      "type": "Internship",
      "institution": "Harvard, Brigham and Women's Hospital and Massachusetts General Hospital",
      "position": "Intern",
      "specialty": "Obstetrics and Gynecology"
    },
    {
      "type": "Residency",
      "institution": "Harvard, Brigham and Women's Hospital and Massachusetts General Hospital",
      "specialty": "Combined Program of Obstetrics and Gynecology"
    },
    {
      "type": "Fellowship",
      "institution": "Duke University Medical Center",
      "specialty": "Gynecologic Oncology"
    }
  ],
  "publications": [
    {
      "title": "Specimen extraction techniques utilized in minimally invasive surgery for uterine cancer and an enlarged uterus: a quality assurance study",
      "pubmed_id": "40926147",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Quian A, Mercier AM, Lam C, Wenham RM, Chon HS, Shahzad MM, Chern JY, Thompson Z, Hoffman MS",
      "journal": "J Robot Surg"
    },
    {
      "title": "Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study",
      "pubmed_id": "40379142",
      "year": "2025",
      "publication_date": "2025 May",
      "authors": "Ahmed KA, Quick AM, Chon HS, Chern JY, Bixel K, Kim Y, Li J, Montejo ME, Dowell RA, Kim S, Fernandez DC, Lam CA, Hakam A, Rosa M, Shafique M, Shahzad MM, Wenham RM",
      "journal": "Int J Radiat Oncol Biol Phys"
    },
    {
      "title": "Exenteration after exenteration: A vulvar pagetoid recurrence following radical resection of urothelial carcinoma",
      "year": "2025",
      "publication_date": "2025 May",
      "authors": "Yasukawa M, Rivera L, Poch MA, Wenham RM, Hakam A, Avila M",
      "journal": "Annals of Surgical Case Reports & Images"
    },
    {
      "title": "Impact of Intraoperative Blood Transfusions on Survival Rates in Ovarian Cancer Patients",
      "pubmed_id": "40294239",
      "pmc_id": "PMC12038196",
      "year": "2025",
      "publication_date": "2025 Jan",
      "authors": "Benyahia S, Avila M, Coughlin E, Mahil A, Riveron A, Luo Y, Wenham R, Huang J",
      "journal": "Cancer Control"
    },
    {
      "title": "Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial",
      "pubmed_id": "39068739",
      "year": "2024",
      "publication_date": "2024 Oct",
      "authors": "Gupta A, O'Cearbhaill RE, Block MS, Hamilton E, Konner JA, Knutson KL, Potts J, Garrett G, Kenney RT, Wenham RM",
      "journal": "Gynecol Oncol"
    },
    {
      "title": "Post-traumatic reactions and quality of life after pelvic exenteration for gynecologic cancer: a retrospective cohort study",
      "pubmed_id": "39404886",
      "year": "2024",
      "publication_date": "2024 Oct",
      "authors": "Thompson LMA, Loecher N, Albizu-Jacob A, Chon HS, Wenham RM, Donovan KA",
      "journal": "Support Care Cancer"
    },
    {
      "title": "To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy",
      "pubmed_id": "38772367",
      "pmc_id": "PMC11190943",
      "year": "2024",
      "publication_date": "2024 Jun",
      "authors": "Strobl MAR, Martin AL, West J, Gallaher J, Robertson-Tessi M, Gatenby R, Wenham R, Maini PK, Damaghi M, Anderson ARA",
      "journal": "Cell Syst"
    },
    {
      "title": "High Financial Hardship among Patients with Advanced Ovarian Cancer",
      "pubmed_id": "38635421",
      "pmc_id": "PMC11152983",
      "year": "2024",
      "publication_date": "2024 Jun",
      "authors": "Vasquez-Trespalacios EM, Rivera Rivera JN, McIntyre M, Santiago-Datil W, Wenham RM, Vadaparampil ST, Buras AL, Conley CC",
      "journal": "J Soc Work End Life Palliat Care"
    },
    {
      "title": "Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study",
      "pubmed_id": "38134754",
      "year": "2024",
      "publication_date": "2024 Feb",
      "authors": "Chan JK, Tian C, Kesterson JP, Lin KY, Darcy K, Richardson MT, Kapp DS, Monk BJ, McNally L, Landrum L, Copeland L, Walker JL, Wenham RM, Phippen N, Spirtos NM, Tewari K, Shahin M, Berry L, Bell JG",
      "journal": "Gynecol Oncol"
    },
    {
      "title": "A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib",
      "pubmed_id": "38759516",
      "pmc_id": "PMC11309890",
      "year": "2024",
      "publication_date": "2024 Aug",
      "authors": "Liu JF, Xiong N, Wenham RM, Wahner-Hendrickson A, Armstrong DK, Chan N, O'Malley DM, Lee JM, Penson RT, Cristea MC, Abbruzzese JL, Matsuo K, Olawaiye AB, Barry WT, Cheng SC, Polak M, Swisher EM, Shapiro GI, Kohn EC, Ivy SP, Matulonis UA",
      "journal": "Gynecol Oncol"
    }
  ],
  "grants": [
    {
      "description": "Title: Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer  \nAward Number: U01CA280849  \nSponsor: National Institutes of Health (NIH)  \nWenham, R. (PD/PI)",
      "title": "Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer",
      "award_number": "U01CA280849",
      "sponsor": "National Institutes of Health (NIH)",
      "source": "NIH",
      "investigators": [
        {
          "name": "Wenham, R.",
          "role": "PD/PI"
        }
      ]
    }
  ],
  "participating_trials": [
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-20187/",
      "trial_id": "20187",
      "title": "Development of Intra-tumor Driver Mutation Prevalence as a Predictor of Efficacy of Targeted Agents",
      "condition": "Gynecological Tumor",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-20497/",
      "trial_id": "20497",
      "title": "A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability and Efficacy of MORAb-202, a Folate Receptor Alpha (FRA)-Targeting Antibody-Drug Conjugate (ADC) in Subjects with Selected Tumor Types",
      "condition": "Gynecological Tumor",
      "intervention": "E7080 (Lenvatinib); Lenvatinib (Lenvima); MORAb-202 ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-21113/",
      "trial_id": "21113",
      "title": "A Phase I Clinical Trial of an Infusion of Autologous T Cells Genetically Engineered with a Chimeric Receptor to Target the Follicle-Stimulating Hormone Receptor in Patients with Recurrent Ovarian Cancer",
      "condition": "Gynecological Tumor",
      "intervention": "FSHR T-Cells (); cyclophosphamide (); cytoxan (cyclophosphamide); fludarabine (Fludarabine phosphate)",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23587/",
      "trial_id": "23587",
      "title": "A Phase 2, Multicenter, Open-Label Study of Lifileucel (Tumor-Infiltrating Lymphocytes [TIL]) in Participants with Previously Treated Advanced Endometrial Cancer",
      "condition": "Gynecological Tumor",
      "intervention": "Aldesleukin (Interleukin-2); IL-2 (Interleukin-2); Interleukin-2 (); Lifileucel (); MESNA (); Proleukin (Interleukin-2); cyclophosphamide (); cytoxan (cyclophosphamide); fludarabine (Fludarabine phosphate)",
      "status": "Open"
    }
  ],
  "lab_page_url": "",
  "google_scholar_url": "",
  "photo_url": "https://www.moffitt.org/globalassets/images/researchers_bio/WenhamRobert_3149.jpg",
  "contact": {
    "contact_url": "https://eforms.moffitt.org/ContactResearchersForm?PERID=3149"
  },
  "content_hash": "8fcff57ac2f9ef84ef44f38949d0a390d3466891d25d004116978d92dec5c6cc",
  "researcher_name": "robert wenham",
  "department": ""
}